I-Mab Reports Third Quarter 2024 Results - PR Newswire
2 days ago · Third Quarter 2024 Financial Results Cash Position As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million , …
OFF
I-Mab Reports Third Quarter 2024 Results - PR Newswire
1 week from now
2 days ago · Third Quarter 2024 Financial Results Cash Position As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million , …
prnewswire.com
OFF
I-Mab Reports Third Quarter 2024 Results - Morningstar
1 week from now
2 days ago · Third Quarter 2024 Financial Results Cash Position As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million , …
morningstar.com
OFF
I-Mab Reports Third Quarter 2024 Results
1 week from now
2 days ago · 2024.11.14. I-Mab Reports Third Quarter 2024 Results ... monotherapy dose range (8-12 mg/kg). The study showed an ORR of 16.3% (7/43), including seven partial responses …
i-mabbiopharma.com
OFF
I-Mab Reports Third Quarter 2024 Results - Nasdaq
1 week from now
Sep 30, 2024 · Third Quarter 2024 Financial Results Cash Position As of September 30, 2024 , the Company had cash and cash equivalents, and short-term investments of $184.4 million , …
nasdaq.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension